A public-private partnership led by the National Institutes of Health to accelerate Alzheimer’s disease drug development has launched a new portal to serve as a data sharing and analysis resource for researchers.

Part of the Accelerating Medicines Partnership (AMP), the AMP- Alzheimer’s Disease (AD) Knowledge Portal and its release of the “first wave” of data “will enable sharing and analyses of large and complex biomedical datasets,” according to NIH. Developed by Sage Bionetworks, a Seattle-based non-profit organization promoting open science, the portal will house several big data projects over the next five years.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access